GlaxoSmithKline corporation issued a voluntary recall of up to six hundred thousand asthma inhalers. These inhalers are more specifically Albuterol based inhalers. These are marketed as Ventolin inhalers.
Three lots of this product is being recalled. HFA 200D inhalers were distributed to hospitals, pharmacies, retailers and wholesalers. The three lot numbers are:
These inhalers are being recalled because of possible leakage which could reduce amount of dosages. These inhalers do not pose a medical risk to current users. Consumers are asked to keep these inhalers.
These inhalers are being removed from existing stock. You can call GlaxoSmithKline at 1-888-825-5249. This company issued a following statement:
“Though the overall benefit risk assessment for Ventolin HFA 200D Inhaler when used at prescribed doses remains favourable, in this situation, there is possible risk to patients of experiencing diminished bronchodilation in the setting of acute bronchospasm if reliant on a rescue inhaler that could potentially not deliver the stated number of actuations. GSK is committed to supplying high quality product and patient satisfaction, and we sincerely regret any inconvenience this recall may cause.”
Future prescriptions of this asthma inhaler should not be affected by this recall.